Oric Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. Let's go ahead and get started. Welcome, everyone, to the 44th annual JPMorgan healthcare conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan.
I'm joined by my Squad, Rati Pine, Priyanka Grover, and Joyce. So, our next presenting company is ORIC presenting on behalf of the company, we have CEO, Jacob Chacko.
Thank you, Anupam. It's my pleasure to speak to you today about ORIC Pharmaceuticals and the important work that we are doing within the oncology space. As always, I'll be making some forward-looking statements. I encourage you to look at our SEC disclosures. So starting on slide 3, ORIC stands for overcoming resistance in cancer, which in a nutshell is the mission of the company.
We've assembled a talented group of drug hunters and drug developers that have worked together for many years at prior leading oncology companies and have developed many
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
